ALT Investors Have Opportunity to Join Altimmune, Inc. Fraud Investigation with the Schall Law Firm
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Altimmune announced "topline results from the IMPACT Phase 2b trial of pemvidutide in metabolic dysfunction-associated steatohepatitis (MASH)," on June 26, 2025. Although the Company characterized the results as 'positive,' it added that 'the effects on fibrosis improvement without worsening of MASH in an ITT analysis were 31.8% and 34.5% for pemvidutide 1.2 mg and 1.8 mg, respectively compared with 25.9% for placebo (differences not statistically significant)." Based on this news, shares of Altimmune fell by 52.18% on the same day.
If you are a shareholder who suffered a loss, click here to participate.
We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at bschall@schallfirm.com.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
an hour ago
- Business Insider
‘A Make or Break Moment,' Says Top Investor About Palantir Stock
Palantir (NASDAQ:PLTR) stock continues to spark debate among investors. While the company is delivering impressive results, driven by a rapidly expanding client base across both public and private sectors, its soaring valuation has raised eyebrows. PLTR now trades at multiples more than 10–20× above typical software peers, prompting questions about how much higher it can realistically go. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. That kind of meteoric rise places investors in a tricky predicament – one can admire the company's trajectory yet hesitate to buy in at such elevated levels. Top investor James Foord articulates this tension well, noting that while Palantir's story remains compelling, the narrative could shift dramatically if upcoming earnings fail to meet the market's lofty expectations. 'Stories and sentiment can change, and the next earnings could be the catalyst for this,' explains the 5-star investor, who ranks among the top 2% of TipRanks' stock pros. Yet, for now, the prevailing sentiment remains optimistic. Foord doesn't necessarily foresee an imminent drop. Instead, he emphasizes the market's broader enthusiasm around Palantir and argues that the company could eventually be crowned a member of the 'Magnificent 7' tech elite. Foord attributes much of Palantir's rise to a potent combination of factors: 'larger-than-life' leadership, a promising tech stack, and the broader AI boom that has fueled investor excitement across the sector. As Morgan Housel famously put it, 'the best story wins,' and Palantir is a textbook case. Its secretive government contracts, ambitious AI platform (AIP), and aura of mystery give the stock an almost mythic appeal. But that same opacity is a double-edged sword. If AIP's value is overestimated or rivals catch up, the story could unravel quickly, especially as operating margins, currently around 44%, may already be peaking. Even a modest slip in profitability could shake investor confidence. Is now a good time to invest in Palantir stock? Foord believes the upside outweighs the risk, despite acknowledging the high-stakes nature of the bet. 'The big upside potential is taking center stage, but there's also a big downfall potential for Palantir if the AI darling falls out of favor,' he concludes, while maintaining his Buy rating on the stock. (To watch Foord's track record, click here) Meanwhile, Wall Street is taking a more cautious stance. With 10 Hold ratings, 3 Buys, and 3 Sells, analysts give PLTR a consensus Hold (i.e. Neutral) rating. Moreover, the average 12-month price target of $104.85 suggests a potential downside of ~32% from current levels. (See ) To find good ideas for stocks trading at attractive valuations, visit TipRanks' Best Stocks to Buy, a tool that unites all of TipRanks' equity insights.
Yahoo
an hour ago
- Yahoo
Palantir Just Hit a Record High. What's the Smart Move Now?
Key Points The tech company's revenue growth rate accelerated in Q1. Palantir's commercial business in the U.S. is seeing explosive growth. The stock's wild valuation leaves no room for error. 10 stocks we like better than Palantir Technologies › Data and artificial intelligence company Palantir (NASDAQ: PLTR) seemed to defy gravity in 2024. Shares more than quadrupled, rising a staggering 340%. With such an incredible rise, you'd be forgiven for guessing that the stock would cool off in 2025. But, so far, the opposite is true. Shares are heating up, rising by more than 105% year to date as of this writing. This has given the tech stock a gain of approximately 800% since the start of 2024. With shares trading at record highs. What should investors do? Does it make sense to buy more shares and hope the momentum continues? Or should investors take a more cautious approach and hold or even sell the stock? Soaring sales One thing Palantir really has going for it is its top-line growth. The tech company posted first-quarter revenue of $884 million, up 39% year over year. Highlighting the company's momentum, this was an acceleration from 36% year-over-year growth in the previous quarter. Fueling Palantir's first quarter of 2025 was 55% year-over-year growth in U.S. revenue. Accounting for $628 million of the quarter's total revenue, the U.S. market is vital for Palantir. Supporting this market was a 71% year-over-year increase in commercial revenue and a 45% jump in government revenue. Zooming out to all of the company's markets, Palantir said in its first-quarter update that it closed 139 deals worth $1 million or greater, 51 deals worth at least $5 million, and 31 deals worth $10 million or more. With these strong results now behind it, management had the confidence to raise full-year revenue guidance. The company said it now expects 2025 revenue to be between $3.890 billion and $3.902 billion. This compares to revenue of about $2.9 billion in 2024. The midpoint of management's 2025 revenue guidance range, therefore, assumes about 36% growth. This impressive top-line growth is bolstering profits. Palantir's first-quarter net income was approximately $214 million, more than double its profit of about $106 million in the year-ago quarter. Comments from Palantir co-founder and CEO Alexander Karp in the company's first-quarter earnings call suggest he believes the company is still in its early innings."We are in the middle of a tectonic shift in the adoption of our software, particularly in the U.S..." Karp noted. "We are delivering the operating system for the modern enterprise in the era of AI." A valuation problem While Palantir's top-line momentum is certainly impressive, there's one big problem for investors: The market seems to have already priced in more rapid growth for years to come. Today, Palantir's market capitalization sits at about $365 billion -- more than 93 times the high end of management's guidance range for full-year 2025 revenue. Using the company's trailing-12-month sales, Palantir currently has a price-to-sales ratio of 123. This would be a high figure even for a price-to-earnings ratio. And what is Palantir's price-to-earnings ratio? It's 672. Yes, you heard that right. It's safe to say that investors have already bid up the stock to a level that prices in the most optimistic assumptions for this company. So, what should investors do? The decision is a personal one -- one that you'll have to make on your own. However, if I owned the stock, I'd sell. And for those who don't own shares, I'd avoid them like the plague at this price. Of course, I could be wrong. It's always possible that Palantir exceeds even my most bullish assumptions. Still, I believe there are likely better places with less risk and greater upside potential for investors to allocate their capital. Palantir is a great company. But expectations are simply too high. Investors would be wise to wait to see if they can buy shares at a better entry price. Should you invest $1,000 in Palantir Technologies right now? Before you buy stock in Palantir Technologies, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Palantir Technologies wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $652,133!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,056,790!* Now, it's worth noting Stock Advisor's total average return is 1,048% — a market-crushing outperformance compared to 180% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 15, 2025 Daniel Sparks and his clients have no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Palantir Technologies. The Motley Fool has a disclosure policy. Palantir Just Hit a Record High. What's the Smart Move Now? was originally published by The Motley Fool
Yahoo
3 hours ago
- Yahoo
NYC official warns businesses will flee 'in droves' if democratic socialist candidate wins mayoral race
New York City democratic socialist mayoral candidate Zohran Mamdani is facing harsh criticism from business owners and local officials in the Big Apple, some of whom warn his progressive platform could drive companies and the middle class out of the city. Councilwoman Vickie Paladino sounded the alarm during an appearance on "America Reports" Friday, claiming Mamdani's proposals would cripple the city's economy and send businesses packing. "We will lose businesses in droves," Paladino argued. "You got NASDAQ, you got Wall Street. They could work anywhere. They could work in Jersey, they could work in Connecticut. They don't need to be in Lower Manhattan." Paladino, a Republican representing parts of Queens, argued that Mamdani's democratic socialist agenda would send businesses fleeing to states with lower costs, such as neighboring New Jersey. Mamdani's Failure To Walk Back These Positions Could Cause Reckoning In Democratic Party: 'Five-alarm Warning' One of Mamdani's most controversial proposals is a plan to launch government-run grocery stores in underserved neighborhoods. The 33-year-old state assemblyman, also from Queens, says the program would aim to combat food insecurity and bring down grocery prices. Read On The Fox News App "As mayor, Zohran will create a network of city-owned grocery stores focused on keeping prices low, not making a profit," his campaign website states. "Without having to pay rent or property taxes, they will reduce overhead and pass on savings to shoppers." Liz Peek: New York's Socialist Nightmare Is Just Beginning But There's Still A Way Out Supporters of Mamdani's proposal, often younger, more progressive Democrats, have pointed to the rising cost of groceries in the city. A study by SmartAsset, a financial advisory website, found that grocery prices in the New York metropolitan area increased by 3.3% between March 2024 and March 2025. This rise was among the highest in the nation, surpassed only by cities such as Honolulu, parts of Florida, and areas near San Diego, California. But not everyone is convinced this type of program could work in the nation's largest city. Gristedes Supermarkets CEO John Catsimatidis compared the plan to failed systems in communist regimes and threatened to close stores if Mamdani is elected. "You're going to end up like Havana," Catsimatidis told "America Reports" on Thursday. "I was there in Havana with Fidel Castro. The shelves were empty. He promised the world to the people. He says, 'Get rid of Batista, and things will be great.' Well, it was all one big lie." Fox News Digital reached out to the Mamdani campaign for comment on both criticisms. City-run Grocery Stores, Defunding Police, Safe Injection Sites: What To Know About Nyc's Next Potential Mayor Paladino had similar concerns. She noted that New York has long been a refuge for immigrants fleeing communism and warned that Mamdani's platform could potentially hurt the Middle Class, especially if small businesses are pushed out. "We lose small business, we lose it all," she said. "We're [going to] lose middle-class people." The concerns over Mamdani's views are something Paladino argues has been brewing in the Democratic Party for some time, starting in schools. "They have been training and indoctrinating," she said. "Now the chickens have come home to roost, and guess what? The Democratic Party cannot control them." David Marcus: Democrat Bus Heading Off The Cliff, As Nyc Socialists Hit Gas Pedal Mamdani's broader platform includes eliminating subway fares, offering free municipal housing and childcare, and ending all Immigration and Customs Enforcement (ICE) operations in the city. He defeated former Gov. Andrew Cuomo last month in a stunning primary victory and secured the Democratic nomination. In November's general election, Mamdani could face Republican Curtis Sliwa, incumbent Mayor Eric Adams, and Cuomo, who remains on the ballot as an article source: NYC official warns businesses will flee 'in droves' if democratic socialist candidate wins mayoral race Solve the daily Crossword
